Bioscience
Dreier LLP Announces Class Action Lawsuit Against Neurocrine Biosciences, Inc.(NBIX)
Published in Drug Law Weekly, July 10th, 2007
Dreier LLP announces that a class action lawsuit was commenced in the United States District Court for the Southern District of California, on behalf of purchasers of the common stock of Neurocrine Biosciences, Inc. ("Neurocrine" or the "Company") (NASDAQ:NBIX) during the period June 20, 2002 through June 23, 2006, inclusive (the "Class Period"). The complaint alleges violations of the federal securities laws, including Section 10(b) of the Securities Exchange Act of 1934.
If you purchased Neurocrine common stock during the Class Period, you may be a member of the proposed Class. You must move the Court on or before August 20, 2007 if you...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-07-10)
More Articles from Drug Law Weekly
- Biomedical Engineering
Leading Biotechnology Organizations Praise Effort and Express Concerns with New Follow-on Biologics Proposal - Clinical Trial Research
Spherix Signs Definitive Agreement for Sale of Information Subsidiary - Drug Development
Healthcare Industry Contributions to Presidential Candidates Top $3.7 Million in 2007, Study Says - Drug Development
Kucinich is '100 Percent on Board' with Health Care Reform, Says Michael Moore - Drug Development
Star Scientific Announces Intent to Pursue Drug Development - Drug Safety
Consumers Union Applauds House Panel Approval of Major Drug Safety Legislation to Protect Patients, Consumers - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
